Evidence map›Paper›PMID 15901990›Full record

ArticleEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)2005

Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk.

J Y Park, L Chen, A Elahi, P Lazarus, M S Tockman

Abstract read
In one paragraph

Article in European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 4 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Pooled it
  3. EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Pooled it
  4. Pooled it
  5. Review
  6. A Bibliometric Analysis of Comorbidity of COPD and Lung Cancer: Research Status and Future Directions.International journal of chronic obstructive pulmonary disease · 2023
    Article
  7. Review
  8. Genetic Determinants of 1,3-Butadiene Metabolism and Detoxification in Three Populations of Smokers with Different Risks of Lung Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Article
  9. Article
  10. Article
  11. Review
  12. Review of studies on metabolic genes and cancer in populations of African descent.Genetics in medicine : official journal of the American College of Medical Genetics · 2010
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J Y ParkDivision of Cancer Prevention and Control, 12902 Magnolia Drive, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. parkj@moffitt.usf.edu
L Chen
A Elahi
P Lazarus
M S Tockman
Moffitt Cancer Center · US

Funding

UDP GLUCURONOSYLTRANSFERASES, DETOXIFICATION OF NNKP01CA068384 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LAZARUS, PHILIP · 1995 to 2005
$8.5M
UDPGLUCURONOSYLTRANSFERASE GENOTYPE AND ORAL CANCER RISKR01DE013158 · NIDCR · UNIVERSITY OF SOUTH FLORIDA · PI LAZARUS, PHILIP · 2000 to 2011
$3.6M
THE BIOMARKER DEVELOPMENT LABORATORY AT MOFFITT (BEDLAM)U01CA084973 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI TOCKMAN, MELVYN S · 1999 to 2004
$2.0M
MOLECULAR MARKERS OF ORAL CANCER RISKR01DE012206 · NIDCR · UNIVERSITY OF SOUTH FLORIDA · PI LAZARUS, PHILIP · 1997 to 2000
$307k
Elucidation of epoxide hydrolase polymorphismsR03CA091314 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI PARK, JONG Y · 2001 to 2002
$145k
NCI NIH HHS CA084973NCI NIH HHS CA91314NCI NIH HHS P01 CA068384NCI NIH HHS R03 CA091314NCI NIH HHS U01 CA084973NIDCR NIH HHS DE12206NIDCR NIH HHS R01 DE013158
6 · The paper itself

Abstract

The human microsomal epoxide hydrolase (EH) gene contains polymorphic alleles, which may be linked to increased risk for tobacco-related lung cancer. The purpose of this study is to screen new polymorphisms and determine whether these polymorphisms can be used to predict individual susceptibility to lung cancer. The polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis was used to screen for polymorphisms in the coding region of the EH gene. Eleven polymorphisms, including previously reported polymorphisms, were identified and the prevalence of these variants was assessed in at least 50 healthy Caucasians and African-Americans. Among the 11 polymorphisms, the prevalence of the amino acid-changing EH polymorphisms in codons 43, 113 and 139 was examined in 182 Caucasian incident cases with primary lung cancer, as well as in 365 frequency-matched controls to examine the role of EH polymorphisms in lung cancer risk. A significant increase in lung cancer risk was observed for predicted high EH activity genotypes (odds ratio (OR) 2.3, 95% confidence interval (CI) 1.2-4.3) as compared with low EH activity genotypes. This association was more pronounced among patients with lung adenocarcinoma (OR 4.7, 95% CI 1.7-13.1). These results suggest that the EH polymorphism plays an important role in lung cancer risk and is linked to tobacco smoke exposure.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticAdenocarcinomaAdultAgedAged, 80 and overBlack or African AmericanCarcinoma, Non-Small-Cell LungEpoxide HydrolasesFemaleGenotypeHumansLung NeoplasmsMaleMiddle AgedOdds RatioEpoxide HydrolasesTobacco Smoke Pollution

Identifiers

PMID15901990
PMCPMC3715303
OpenAlexW2028202801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.